| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.0000109792.43271.47 |
| P698 | PubMed publication ID | 14656930 |
| P50 | author | José M García-Verdugo | Q42446274 |
| P2093 | author name string | André M | |
| Perez A | |||
| Casteilla L | |||
| Pénicaud L | |||
| Menard C | |||
| Puceat M | |||
| Planat-Bénard V | |||
| P433 | issue | 2 | |
| P304 | page(s) | 223-229 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells | |
| P478 | volume | 94 |
| Q36380168 | "In vitro" and multicolor phenotypic characterization of cell subpopulations identified in fresh human adipose tissue stromal vascular fraction and in the derived mesenchymal stem cells |
| Q40918462 | 5-Azacytidine is insufficient for cardiogenesis in human adipose-derived stem cells |
| Q33768499 | A brief review: adipose-derived stem cells and their therapeutic potential in cardiovascular diseases |
| Q33827927 | A comparative study of the influence of two types of PHEMA stents on the differentiation of ASCs to myocardial cells |
| Q41436589 | A novel composition for the culture of human adipose stem cells which includes complement C3 |
| Q28534582 | A xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses |
| Q44067248 | ADSCs differentiated into cardiomyocytes in cardiac microenvironment |
| Q34204172 | Adipogenic potential of adipose stem cell subpopulations. |
| Q58610536 | Adipose Stem Cell Translational Applications: From Bench-to-Bedside |
| Q37735358 | Adipose Tissue-Derived Stem Cells for Myocardial Regeneration |
| Q47135035 | Adipose stem cells for bone tissue repair |
| Q53187816 | Adipose stromal vascular fraction improves cardiac function in chronic myocardial infarction through differentiation and paracrine activity. |
| Q37825285 | Adipose tissue as a stem cell source for musculoskeletal regeneration |
| Q35715553 | Adipose tissue stem cells meet preadipocyte commitment: going back to the future |
| Q37236815 | Adipose tissue-derived cells improve cardiac function following myocardial infarction |
| Q36655868 | Adipose tissue-derived cells: from physiology to regenerative medicine. |
| Q26795749 | Adipose tissue-derived stem cells as a therapeutic tool for cardiovascular disease |
| Q38126956 | Adipose tissue-derived stem cells in clinical applications. |
| Q37766152 | Adipose tissue-derived stem cells: the friendly side of a classic cardiovascular foe. |
| Q38059619 | Adipose tissue: friend or foe? |
| Q58999088 | Adipose-Derived Stem Cells in Tissue Regeneration: A Review |
| Q37092184 | Adipose-derived cells |
| Q38085695 | Adipose-derived mesenchymal stem cells and regenerative medicine |
| Q26822936 | Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design |
| Q47835369 | Adipose-derived stem cell adhesion on laminin-coated microcarriers improves commitment toward the cardiomyogenic lineage |
| Q91684779 | Adipose-derived stem cells contribute to cardiovascular remodeling |
| Q37813497 | Adipose-derived stem cells for myocardial infarction |
| Q28301763 | Adipose-derived stem cells for regenerative medicine |
| Q37357278 | Adipose-derived stem cells for soft tissue reconstruction. |
| Q30440478 | Adipose-derived stem cells for the regeneration of damaged tissues |
| Q34219119 | Adipose-derived stromal cell therapy improves cardiac function after coronary occlusion in rats |
| Q38028031 | Adipose-derived stromal cells (ASCs). |
| Q27021721 | Adipose-derived stromal/stem cells: a primer |
| Q24797989 | Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro |
| Q36815983 | Adult stem cells and heart regeneration |
| Q37779933 | Adult stem cells for cardiac tissue engineering |
| Q36842703 | Adult stem cells for cardiovascular diseases: the adipose tissue potential |
| Q26765277 | Advances in Adipose-Derived Stem Cells Isolation, Characterization, and Application in Regenerative Tissue Engineering |
| Q89942853 | Advances in regenerative therapy: A review of the literature and future directions |
| Q33957120 | Aesthetic cardiology: adipose-derived stem cells for myocardial repair |
| Q38613534 | An Overview of Neural Differentiation Potential of Human Adipose Derived Stem Cells |
| Q35114912 | Anti-inflammatory peptides from cardiac progenitors ameliorate dysfunction after myocardial infarction |
| Q38247754 | Application of adipose-derived stem cells in heart disease |
| Q36479109 | Application of stem cells for cardiovascular grafts tissue engineering. |
| Q88887066 | Ascorbic acid induces cardiac differentiation of white adipose tissue-derived stem cells |
| Q90285572 | Autologous transplantation of adipose-derived stem cells improves functional recovery of skeletal muscle without direct participation in new myofiber formation |
| Q35014015 | BMP7 drives human adipogenic stem cells into metabolically active beige adipocytes |
| Q42555941 | Beyond the adventitia: exploring the outer limits of the blood vessel wall |
| Q26865867 | Biodegradable Polymers and Stem Cells for Bioprinting |
| Q38519839 | Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering |
| Q38102882 | Biomaterials and bioengineering tomorrow's healthcare |
| Q47637334 | Biomechanical Regulation of Mesenchymal Stem Cells for Cardiovascular Tissue Engineering |
| Q34271229 | Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art |
| Q27006710 | Bone marrow mononuclear cells and acute myocardial infarction |
| Q37951953 | Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. |
| Q42696518 | Cardiac Adipose-Derived Stem Cells Exhibit High Differentiation Potential to Cardiovascular Cells in C57BL/6 Mice |
| Q92483853 | Cardiac Regeneration by Statin-Polymer Nanoparticle-Loaded Adipose-Derived Stem Cell Therapy in Myocardial Infarction |
| Q37371934 | Cardiac cell repair therapy: a clinical perspective |
| Q37866145 | Cardiac regeneration: different cells same goal |
| Q38175372 | Cardiac stem cell biology: glimpse of the past, present, and future. |
| Q37261443 | Cardiac tissue engineering using stem cells |
| Q39630514 | Cardiogenesis from human embryonic stem cells |
| Q91710993 | Cardiogenic Differentiation of Murine Bone Marrow-Derived Mesenchymal Stem Cells by 5-Azacytidine: A Follow-up In vitro Study |
| Q37319214 | Cardiogenic differentiation and transdifferentiation of progenitor cells |
| Q53588305 | Cardiomyocyte differentiation induced in cardiac progenitor cells by cardiac fibroblast-conditioned medium. |
| Q37002682 | Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis |
| Q51659834 | Cardiosphere conditioned media influence the plasticity of human mediastinal adipose tissue-derived mesenchymal stem cells. |
| Q53508391 | Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials. |
| Q27001159 | Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions |
| Q38226693 | Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences. |
| Q35874262 | Cell therapy: an evolutionary development of transfusion medicine |
| Q37118515 | Cell transplantation for cardiac regeneration: where do we stand? |
| Q36667275 | Cell-based approaches for cardiac repair |
| Q37638266 | Cellular cardiomyoplasty and cardiac regeneration |
| Q36236544 | Cellular cardiomyoplasty for myocardial regeneration |
| Q37583950 | Challenges in cardiac tissue engineering |
| Q42019775 | Characterization of ocular surface epithelial and progenitor cell markers in human adipose stromal cells derived from lipoaspirates. |
| Q30477973 | Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells |
| Q56916548 | Co-transplantation of adipose and bone marrow derived stromal cells for treatment of osteonecrosis of femoral head |
| Q38317834 | Common expression of stemness molecular markers and early cardiac transcription factors in human Wharton's jelly-derived mesenchymal stem cells and embryonic stem cells |
| Q39175052 | Comparison of angiogenic potential between prevascular and non-prevascular layered adipose-derived stem cell-sheets in early post-transplanted period |
| Q42452907 | Comparison of morphology and biocompatibility of acellular nerve scaffolds processed by different chemical methods |
| Q35083584 | Comparison of random and aligned PCL nanofibrous electrospun scaffolds on cardiomyocyte differentiation of human adipose-derived stem cells |
| Q38063849 | Concise review: cell therapy and tissue engineering for cardiovascular disease |
| Q33586957 | Controlled angiogenesis in the heart by cell-based expression of specific vascular endothelial growth factor levels |
| Q54469013 | Dedifferentiated fat cells convert to cardiomyocyte phenotype and repair infarcted cardiac tissue in rats. |
| Q59113673 | Development of Bioactive Patch for Maintenance of Implanted Cells at the Myocardial Infarcted Site |
| Q39791530 | Development of bioartificial myocardium using stem cells and nanobiotechnology templates |
| Q92714749 | Differentiation of brown adipose-derived stem cells into cardiomyocyte-like cells is regulated by a combination of low 5-azacytidine concentration and bone morphogenetic protein 4 |
| Q33469641 | Differentiation of human adipose tissue SVF cells into cardiomyocytes |
| Q37295270 | Differentiation of human adipose-derived stem cells into beating cardiomyocytes. |
| Q30731784 | Direct hydrogel encapsulation of pluripotent stem cells enables ontomimetic differentiation and growth of engineered human heart tissues |
| Q37479448 | Distinct roles of glycogen synthase kinase (GSK)-3alpha and GSK-3beta in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells. |
| Q54432158 | Distinct stem cells subpopulations isolated from human adipose tissue exhibit different chondrogenic and osteogenic differentiation potential. |
| Q37532742 | Early translation of adipose-derived cell therapy for cardiovascular disease. |
| Q47595890 | Effects of donor age on human adipose-derived adherent stromal cells under oxidative stress conditions |
| Q33794850 | Efficient isolation of cardiac stem cells from brown adipose |
| Q37653423 | Electrophysiological challenges of cell-based myocardial repair |
| Q30401607 | Enzymatic and non-enzymatic isolation systems for adipose tissue-derived cells: current state of the art. |
| Q43532584 | Epigenetic signature of early cardiac regulatory genes in native human adipose-derived stem cells |
| Q99635291 | Fat grafts enriched with adipose-derived stem cells |
| Q92943552 | Fibrin Hydrogels for Endothelialized Liver Tissue Engineering with a Predesigned Vascular Network |
| Q53642381 | From heterogeneity to plasticity in adipose tissues: site-specific differences. |
| Q26865425 | Gene and cell therapies for the failing heart to prevent sudden arrhythmic death |
| Q51028254 | General overview of the Seventh International Symposium on Stem Cell Therapy and Cardiovascular Innovations. |
| Q43046311 | Growth Properties and Pluripotency Marker Expression of Spontaneously Formed Three-dimensional Aggregates of Human Adipose-derived Stem Cells. |
| Q47763751 | Human adipose tissue stromal vascular fraction cells differentiate depending on distinct types of media |
| Q36490813 | Human adipose tissue-derived SSEA-4 subpopulation multi-differentiation potential towards the endothelial and osteogenic lineages |
| Q54420461 | Human adipose tissue-derived adult stem cells can lead to multiorgan engraftment. |
| Q42265237 | Human adipose tissue-derived stem cells exhibit proliferation potential and spontaneous rhythmic contraction after fusion with neonatal rat cardiomyocytes |
| Q39248513 | Human adipose-derived stem cells for the treatment of intracerebral hemorrhage in rats via femoral intravenous injection |
| Q37825466 | Human cardiomyogenesis and the need for systems biology analysis |
| Q38048723 | Human mesenchymal stem cells: from immunophenotyping by flow cytometry to clinical applications |
| Q37854071 | Hypoxia and adipose-derived stem cell-based tissue regeneration and engineering. |
| Q34114841 | IFATS collection: Human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function |
| Q43012008 | Icariin-mediated differentiation of mouse adipose-derived stem cells into cardiomyocytes |
| Q36737033 | Immune response to stem cells and strategies to induce tolerance |
| Q94503661 | Immunomodulatory Effect of Adipose-Derived Stem Cells: The Cutting Edge of Clinical Application |
| Q39651637 | Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction |
| Q64098014 | Improved Efficiency of Cardiomyocyte-Like Cell Differentiation from Rat Adipose Tissue-Derived Mesenchymal Stem Cells with a Directed Differentiation Protocol |
| Q37872602 | In vitro Differentiation Potential of Mesenchymal Stem Cells |
| Q34644569 | In vitro culture, determination, and directed differentiation of adult adipose-derived stem cells towards cardiomyocyte-like cells induced by angiotensin II. |
| Q34942078 | Incorporation of gold-coated microspheres into embryoid body of human embryonic stem cells for cardiomyogenic differentiation |
| Q33607890 | Induced differentiation of adipose-derived stromal cells into myoblasts |
| Q35183297 | Inhibition of oxygen-glucose deprivation-induced apoptosis of human adipose-derived stem cells by genetic modification with antiapoptotic protein bcl-2. |
| Q35101851 | Interphase FISH demonstrates that human adipose stromal cells maintain a high level of genomic stability in long-term culture |
| Q34274484 | Intracoronary and retrograde coronary venous myocardial delivery of adipose-derived stem cells in swine infarction lead to transient myocardial trapping with predominant pulmonary redistribution |
| Q40398723 | Intramyocardially Transplanted Neonatal Cardiomyocytes (NCMs) Show Structural and Electrophysiological Maturation and Integration and Dose-Dependently Stabilize Function of Infarcted Rat Hearts |
| Q33598812 | Isolation, culture and identification of human adipose-derived stem cells |
| Q33531400 | Local transplantation of human multipotent adipose-derived stem cells accelerates fracture healing via enhanced osteogenesis and angiogenesis |
| Q39366416 | Long-term engraftment and angiogenic properties of lentivirally transduced adipose tissue-derived stromal cells |
| Q37506545 | Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help? |
| Q51610305 | Mechanisms underlying the osteo- and adipo-differentiation of human mesenchymal stem cells. |
| Q41899828 | Mesenchymal Progenitor Cells: Tissue Origin, Isolation and Culture |
| Q34147506 | Mesenchymal markers on human adipose stem/progenitor cells |
| Q22252511 | Mesenchymal stem cell delivery strategies to promote cardiac regeneration following ischemic injury |
| Q38210870 | Mesenchymal stem cell insights: prospects in cardiovascular therapy |
| Q47587274 | Mesenchymal stem cell-derived extracellular vesicles: a glimmer of hope in treating Alzheimer's disease |
| Q37196614 | Mesenchymal stem cells in tissue repairing and regeneration: Progress and future |
| Q46553390 | Mimicking native extracellular matrix with phytic acid-crosslinked protein nanofibers for cardiac tissue engineering |
| Q36477618 | Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease |
| Q30595510 | Mouse adipose tissue stromal cells give rise to skeletal and cardiomyogenic cell sub-populations. |
| Q35013033 | Myocardial infarction and stem cells |
| Q42242472 | Myogenic differentiation and reparative activity of stromal cells derived from pericardial adipose in comparison to subcutaneous origin |
| Q37977128 | Nano-regenerative medicine towards clinical outcome of stem cell and tissue engineering in humans. |
| Q38074105 | Natural ECM as biomaterial for scaffold based cardiac regeneration using adult bone marrow derived stem cells. |
| Q36103343 | Non-canonical Wnt signaling enhances differentiation of Sca1+/c-kit+ adipose-derived murine stromal vascular cells into spontaneously beating cardiac myocytes |
| Q38214092 | Non-hematopoietic stem cells in umbilical cord blood. |
| Q83040689 | Obesity and risk of myocardial infarction: the INTERHEART study |
| Q30837375 | Obtaining spontaneously beating cardiomyocyte-like cells from adipose-derived stromal vascular fractions cultured on enzyme-crosslinked gelatin hydrogels |
| Q39786420 | Osteogenic differentiation of two distinct subpopulations of human adipose-derived stem cells: an in vitro and in vivo study |
| Q84404913 | Over-expression of Nkx2.5 and/or cardiac α-actin inhibit the contraction ability of ADSCs-derived cardiomyocytes |
| Q37747052 | Peritoneal adipocytes and their role in inflammation during peritoneal dialysis |
| Q43553019 | Permanent activation of HMGA2 in lipomas mimics its temporal physiological activation linked to the gain of adipose tissue |
| Q82662208 | Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes |
| Q38160455 | Potential and clinical utility of stem cells in cardiovascular disease. |
| Q37993142 | Potential for stem cell use in congenital heart disease |
| Q44970917 | Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice |
| Q94077144 | Previews |
| Q36881332 | Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction |
| Q36275672 | Progenitor cells in vascular disease. |
| Q53029346 | Proliferation and differentiation of human adipose-derived mesenchymal stem cells (ASCs) into osteoblastic lineage are passage dependent. |
| Q41296731 | Promoting effect of small molecules in cardiomyogenic and neurogenic differentiation of rat bone marrow-derived mesenchymal stem cells |
| Q37048246 | Promotion of wound healing using adipose-derived stem cells in radiation ulcer of a rat model |
| Q37807086 | REVIEW: Stem Cell Therapy in Cardiovascular Disorders |
| Q33658949 | Rat adipose tissue-derived stem cells transplantation attenuates cardiac dysfunction post infarction and biopolymers enhance cell retention. |
| Q90670535 | Recent Advance in Source, Property, Differentiation, and Applications of Infrapatellar Fat Pad Adipose-Derived Stem Cells |
| Q45395177 | Recombinant sendai virus-mediated gene transfer to adipose tissue-derived stem cells (ASCs). |
| Q38032473 | Regenerating cardiac cells: insights from the bench and the clinic |
| Q34447802 | Regenerative therapy after cancer: what are the risks? |
| Q34163390 | Regional anatomic and age effects on cell function of human adipose-derived stem cells |
| Q39154442 | Regulation of the microenvironment for cardiac tissue engineering |
| Q27320256 | Rho-associated protein kinases play an important role in the differentiation of rat adipose-derived stromal cells into cardiomyocytes in vitro |
| Q57357201 | Role of CD9 in proliferation and proangiogenic action of human adipose-derived mesenchymal stem cells |
| Q39307264 | Short-term mechanical stretch fails to differentiate human adipose-derived stem cells into cardiovascular cell phenotypes |
| Q53060770 | Single cell-derived clones from human adipose stem cells present different immunomodulatory properties. |
| Q36426360 | Sources of cardiomyocytes for stem cell therapy: an update |
| Q30492259 | Spontaneously beating cardiomyocytes derived from white mature adipocytes. |
| Q85240790 | Stem and progenitor cell-based therapy approaches: current developments on treatment of acute myocardial infarction and chronic ischemic cardiomyopathy |
| Q37386765 | Stem cell technology using bioceramics: hard tissue regeneration towards clinical application |
| Q37766194 | Stem cell therapy for chronic myocardial infarction |
| Q40097837 | Stem cell therapy for heart failure: the science and current progress. |
| Q38761212 | Stem cell therapy for ischemic heart diseases |
| Q34315088 | Stem cell treatment of the heart: a review of its current status on the brink of clinical experimentation |
| Q36842866 | Stem cells and cardiac regeneration |
| Q37766151 | Stem cells and cardiac repair: a critical analysis |
| Q38273056 | Stem cells for cardiac regeneration and possible roles of the transforming growth factor-β superfamily |
| Q37851859 | Stem cells from adipose tissue. |
| Q34817504 | Stromal vascular fraction transplantation as an alternative therapy for ischemic heart failure: anti-inflammatory role |
| Q34103764 | Stromal vascular progenitors in adult human adipose tissue |
| Q48762228 | Study of internalization and viability of multimodal nanoparticles for labeling of human umbilical cord mesenchymal stem cells. |
| Q42701647 | Study of the chlorpyrifos neurotoxicity using neural differentiation of adipose tissue-derived stem cells |
| Q33539819 | Surface-patterned electrode bioreactor for electrical stimulation |
| Q37341443 | TBX18 gene induces adipose-derived stem cells to differentiate into pacemaker-like cells in the myocardial microenvironment. |
| Q46426692 | Targeting the pathway of GSK-3β/nerve growth factor to attenuate post-infarction arrhythmias by preconditioned adipose-derived stem cells |
| Q38851187 | Tbx18-dependent differentiation of brown adipose tissue-derived stem cells toward cardiac pacemaker cells |
| Q37186709 | The epigenetics of adult (somatic) stem cells |
| Q34025653 | The facial autologous muscular injection (FAMI) procedure: an anatomically targeted deep multiplane autologous fat-grafting technique using principles of facial fat injection |
| Q37791174 | The pivotal role of VEGF in adipose-derived-stem-cell-mediated regeneration. |
| Q41901872 | The potential of GMP-compliant platelet lysate to induce a permissive state for cardiovascular transdifferentiation in human mediastinal adipose tissue-derived mesenchymal stem cells. |
| Q49971923 | The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy |
| Q34634535 | The relative contribution of paracine effect versus direct differentiation on adipose-derived stem cell transplantation mediated cardiac repair |
| Q35661004 | The role of stem cells for treatment of cardiovascular disease |
| Q34011497 | The stem cell adjuvant with Exendin-4 repairs the heart after myocardial infarction via STAT3 activation |
| Q38281750 | The war against heart failure: the Lancet lecture |
| Q59128840 | Therapeutic approaches for cardiac regeneration and repair |
| Q36909360 | Therapeutic potential of adult progenitor cells in cardiovascular disease |
| Q42121480 | Therapeutic potential of human adipose stem cells in a rat myocardial infarction model |
| Q47131423 | Three Dimensional Honeycomb Patterned Fibrinogen Based Nanofibers Induce Substantial Osteogenic Response of Mesenchymal Stem Cells |
| Q40199212 | Tissue engineering approaches for the development of a contractile cardiac patch. |
| Q37143902 | Tissue engineering craniofacial defects with adult stem cells? Are we ready yet? |
| Q37165815 | Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines |
| Q50533414 | Transplantation of SNAP-treated adipose tissue-derived stem cells improves cardiac function and induces neovascularization after myocardium infarct in rats. |
| Q50637278 | Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction. |
| Q37286681 | Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice |
| Q33683767 | Unchain my heart: the scientific foundations of cardiac repair |
| Q53608261 | [Future perspectives in the treatment of heart failure: from cell transplantation to cardiac regeneration]. |
| Q83514683 | [Mesenchymal stromal cells: Biological properties and clinical prospects] |
| Q83009574 | [Stem cells treatment for patients with heart diseases] |
| Q80357363 | [The hopes of the mesenchymal stem cells in regenerative medicine] |
| Q41027617 | in vitro development of bioimplants made up of elastomeric scaffolds with peptide gel filling seeded with human subcutaneous adipose tissue-derived progenitor cells. |
Search more.